SEC Form 4 · accession 0001562180-18-002114
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard L. Weiner
Director
Period of report
Apr 30, 2018
Accepted (ET)
May 2, 2018 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director stock option (right to buy)F1 | $1.79 | Apr 30, 2018 | A | 26,250 | A | — | Apr 30, 2028 | Class A common stock | 26,250 | 26,250 | D |
Explanation of responses
- F1An option to acquire 2,813 shares is immediately vested on April 30, 2018. The remaining portion of the option grant (an option to acquire 23,437 shares) vests in monthly equal installments over the three year period beginning on April 30, 2018.